We are live on ! Find out more
TGI

TRV GP III Portfolio holdings

AUM $6.14M
1-Year Est. Return 45.44%
This Fund
S&P 500
This Quarter Est. Return
-15.02%
1 Year Est. Return
+45.44%
3 Year Est. Return
+169.98%
5 Year Est. Return
+802.39%
10 Year Est. Return
AUM
$224M
AUM Growth
-$76.4M
Cap. Flow
-$28.8M
Cap. Flow %
-12.85%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
VYGR icon
Voyager Therapeutics
VYGR
+$28.8M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYGR icon
1
Voyager Therapeutics
VYGR
$189M
$121M 54%
6,391,176
-1,500,000
-19% -$28.8M
NTGN
2
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$83.2M 37.15%
9,741,636
JNCE
3
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$19.8M 8.85%
3,048,780

Similar funds

TRV GP III's Q3 2018 Portfolio in Review

As of Q3 2018, TRV GP III held 3 positions worth $224M, down 25% from $300M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TRV GP III withdrew a net $28.8M in Q3 2018, reducing 1 holding. Its largest reduction was Voyager Therapeutics, cutting an estimated $28.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP III's biggest Q3 2018 reduction was Voyager Therapeutics, cutting an estimated $28.8M.
  • TRV GP III's ten largest holdings make up 100% of its $224M portfolio in Q3 2018.
  • TRV GP III opened 0 new positions and closed 0 in Q3 2018.
  • TRV GP III's portfolio value fell 25% quarter-over-quarter to $224M.

Based on TRV GP III's 13F filing for Q3 2018, filed 29 Oct 2018.